Tayla Heavican

10PUBLICATIONS
119CO-AUTHORS
Haematological tumoursInnate immunityMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 28, 2026
Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype.

|Nov 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia.

Caroline R M Wiggers, Eugene Y Cho, Merve Ozdemir

|Jul 31, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma.

Tayla B Heavican-Foral, Felix Korell, Irene Scarfò

|Mar 19, 2025
Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia.

Caroline R M Wiggers, Burak Yüzügüldü, Nathanial G Tadros

|Nov 16, 2024
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.

Waseem Lone, Alyssa Bouska, Tyler A Herek

|Jan 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Bimarzhan Assatova, Robert Willim, Christopher Trevisani

Pageof 2

Frequent Collaborators

3 joint publications

David M Weinstock

3 joint publications

Giorgio Inghirami

3 joint publications

Catalina Amador

3 joint publications

Jens G Lohr